SCHEMBL3260285

SCHEMBL3260285

Brc1ccc2nc3ccccc3cc2c1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
GLA P06280 3/20 0.52
HPGD P15428 3/20 0.52
MAPT P10636 3/20 0.52
ACHE P22303 2/20 0.52
KDM4E B2RXH2 4/20 0.52
KMT2A Q03164 3/20 0.52
GAA P10253 2/20 0.52
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
LMNA P02545 1/20 0.52
POLB P06746 1/20 0.52
PTBP1 P26599 1/20 0.52
RCE1 Q9Y256 1/20 0.52
TDP1 Q9NUW8 2/20 0.44
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
NQO2 P16083 5/20 0.40
HTR3A P46098 1/20 0.40
IDO1 P14902 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4299906 0.81 ALDH1A1 (0.70) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL28265821 0.80 ESR1 (0.57) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL902308 0.80 ALDH1A1 (0.60) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL8003446 0.78 KDM1A (0.45) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL30857473 0.77 ALDH1A1 (0.64) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL11905392 0.77 ALDH1A1 (0.64) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL28265823 0.74 ALDH1A1 (0.53) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL30853545 0.74 ALDH1A1 (0.58) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL29712310 0.74 ALDH1A1 (0.58) ALDH1A1GLAHPGDMAPTACHE
SCHEMBL11690096 0.74 ALDH1A1 (0.58) ALDH1A1GLAHPGDMAPTACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0747701-B1 Micelle protection assay GEN PROBE INC (US) 2001-12-05 EP claimed
CN-107311925-A One kind contains acridine compounds and its organic luminescent device 长春海谱润斯科技有限公司 2017-11-03 CN disclosed
US-7651746-B2 Halogenated bisdiarylaminopolycyclic aromatic compounds and polymers thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-01-26 US disclosed
US-20070126345-A1 Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-06-07 US disclosed
WO-2005049546-A1 HALOGENATED BISDIARYLAMINOPOLYCYLIC AROMATIC COMPOUNDS AND POLYMERS THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070126345-A1 Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof AHR, AADAC, ARNT ALDH1A1 667/4885GLA 2598/4885HPGD 1563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.